과제정보
This work was supported by the Societe Francaise de Medecine Vasculaire (SFMV) and the CHU Rennes (AO CORECT 2014).
참고문헌
- Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002;39:930-936 https://doi.org/10.1053/ajkd.2002.32766
- Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, et al. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol 2009;4:1162-1169 https://doi.org/10.2215/CJN.00550109
- Koch C, Chaudru S, Lederlin M, Jaquinandi V, Kaladji A, Mahe G. Remote ischemic preconditioning and contrast-induced nephropathy: a systematic review. Ann Vasc Surg 2016;32:176-187 https://doi.org/10.1016/j.avsg.2015.10.017
- Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl 2006;(100):S11-S15
- Mehran R, Dangas GD, Weisbord SD. Contrast-associated acute kidney injury. N Engl J Med 2019;380:2146-2155 https://doi.org/10.1056/NEJMra1805256
- van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, et al. Post-contrast acute kidney injury - part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2018;28:2845-2855 https://doi.org/10.1007/s00330-017-5246-5
- van der Molen AJ, Reimer P, Dekkers IA, Bongartz G, Bellin MF, Bertolotto M, et al. Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR Contrast Medium Safety Committee guidelines. Eur Radiol 2018;28:2856-2869 https://doi.org/10.1007/s00330-017-5247-4
- Luk L, Steinman J, Newhouse JH. Intravenous contrast-induced nephropathy-the rise and fall of a threatening idea. Adv Chronic Kidney Dis 2017;24:169-175 https://doi.org/10.1053/j.ackd.2017.03.001
- Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahyet M, al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-1399
- Baumgartner H, Falk V, Bax JJ, Bonis MD, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Rev Esp Cardiol (Engl Ed) 2018;71:110
- Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, et al. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the american college of cardiology task force on clinical expert consensus documents. J Am Coll Cardiol 2017;69:1313-1346 https://doi.org/10.1016/j.jacc.2016.12.006
- Geft IL, Fishbein MC, Ninomiya K, Hashida J, Chaux E, Yano J, et al. Intermittent brief periods of ischemia have a cumulative effect and may cause myocardial necrosis. Circulation 1982;66:1150-1153 https://doi.org/10.1161/01.CIR.66.6.1150
- Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136 https://doi.org/10.1161/01.CIR.74.5.1124
- Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation 2012;126:296-303 https://doi.org/10.1161/CIRCULATIONAHA.112.096370
- Igarashi G, Iino K, Watanabe H, Ito H. Remote ischemic pre-conditioning alleviates contrast-induced acute kidney injury in patients with moderate chronic kidney disease. Circ J 2013;77:3037-3044 https://doi.org/10.1253/circj.CJ-13-0171
- Yamanaka T, Kawai Y, Miyoshi T, Mima T, Takagaki K, Tsukuda S, et al. Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction: a randomized controlled trial. Int J Cardiol 2015;178:136-141 https://doi.org/10.1016/j.ijcard.2014.10.135
- Zhou F, Song W, Wang Z, Yin L, Yang S, Yang F, et al. Effects of remote ischemic preconditioning on contrast induced nephropathy after percutaneous coronary intervention in patients with acute coronary syndrome. Medicine (Baltimore) 2018;97:e9579
- Zagidullin NS, Dunayeva AR, Plechev VV, Gilmanov AZ, Zagidullin SZ, Er F, et al. Nephroprotective effects of remote ischemic preconditioning in coronary angiography. Clin Hemorheol Microcirc 2017;65:299-307 https://doi.org/10.3233/CH-16184
- Ghaemian A, Yazdani J, Azizi S, Farsavian AA, Nabati M, Malekrah A, et al. Remote ischemic preconditioning to reduce contrast-induced acute kidney injury in chronic kidney disease: a randomized controlled trial. BMC Nephrol 2018;19:373
- Healy DA, Feeley I, Keogh CJ, Scanlon TG, Hodnett PA, Stack AG, et al. Remote ischemic conditioning and renal function after contrast-enhanced CT scan: a randomized trial. Clin Invest Med 2015;38:E110-E118 https://doi.org/10.25011/cim.v38i3.22706
- Roubille F, Macia JC, Ivanes F, Angoulvant D, Mateus V, Belle L, et al. Effects of remote ischemic conditioning on kidney injury in at-risk patients undergoing elective coronary angiography (PREPARE study): a multicenter, randomized clinical trial. Sci Rep 2019;9:11985
- Valappil SP, Kunjukrishnapillai S, Viswanathan S, Koshy AG, Gupta PN, Velayudhan RV, et al. Remote ischemic preconditioning for prevention of contrast induced nephropathy-insights from an Indian study. Indian Heart J 2018;70:857-863 https://doi.org/10.1016/j.ihj.2017.11.012
- Moretti C, Cerrato E, Cavallero E, Lin S, Rossi ML, Picchi A, et al. The EUROpean and Chinese cardiac and renal Remote Ischemic Preconditioning Study (EURO-CRIPS CardioGroup I): a randomized controlled trial. Int J Cardiol 2018;257:1-6 https://doi.org/10.1016/j.ijcard.2017.12.033
- Menting TP, Sterenborg TB, de Waal Y, Donders R, Wever KE, Lemson MS, et al. Remote ischemic preconditioning to reduce contrast-induced nephropathy: a randomized controlled trial. Eur J Vasc Endovasc Surg 2015;50:527-532 https://doi.org/10.1016/j.ejvs.2015.04.002
- Weisbord SD, Palevsky PM. Prevention of contrast-induced nephropathy with volume expansion. Clin J Am Soc Nephrol 2008;3:273-280 https://doi.org/10.2215/CJN.02580607
- Pranata R, Tondas AE, Vania R, Toruan MPL, Lukito AA, Siswanto BB. Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: systematic review and meta-analysis of randomized controlled trials. Catheter Cardiovasc Interv 2020 Jan 8 [Epub]. https://doi.org/10.1002/ccd.28709
- Zhou CC, Yao WT, Ge YZ, Xu LW, Wu R, Gao XF, et al. Remote ischemic conditioning for the prevention of contrast-induced acute kidney injury in patients undergoing intravascular contrast administration: a meta-analysis and trial sequential analysis of 16 randomized controlled trials. Oncotarget 2017;8:79323-79336 https://doi.org/10.18632/oncotarget.18106
- Hu J, Liu S, Jia P, Xu X, Song N, Zhang T, et al. Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis. Crit Care 2016;20:111
- Harkonen S, Kjellstrand C. Contrast nephropathy. Am J Nephrol 1981;1:69-77 https://doi.org/10.1159/000166493
- Katzberg RW, Newhouse JH. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe? Radiology 2010;256:21-28 https://doi.org/10.1148/radiol.10092000
- Khan E, Batuman V, Lertora JJ. Emergence of biomarkers in nephropharmacology. Biomark Med 2010;4:805-814 https://doi.org/10.2217/bmm.10.115
- McIlroy DR, Wagener G, Lee HT. Biomarkers of acute kidney injury: an evolving domain. Anesthesiology 2010;112:998-1004 https://doi.org/10.1097/ALN.0b013e3181cded3f
- Benohr P, Grenz A, Hartmann JT, Muller GA, Blaschke S. Cystatin C--a marker for assessment of the glomerular filtration rate in patients with cisplatin chemotherapy. Kidney Blood Press Res 2006;29:32-35 https://doi.org/10.1159/000092485
- Nijssen EC, Rennenberg RJ, Nelemans PJ, Essers BA, Janssen MM, Vermeeren MA, et al. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial. Lancet 2017;389:1312-1322 https://doi.org/10.1016/S0140-6736(17)30057-0